期刊文献+

影响胶质母细胞瘤全切术后患者预后的相关因素分析 被引量:1

Affect the Glioblastoma Cut all of the Factors of the Prognosis of Patients with Postoperative
下载PDF
导出
摘要 目的分析影响胶质母细胞瘤全切术后患者预后的相关因素。方法方便选取该院2010年3月—2011年2月期间收治的70例胶质母细胞瘤全切患者,所有患者均经过手术切除90%以上的肿瘤,意识及精神状况良好。男34例,女36例,年龄<55岁47例,≥55岁23例,分析患者的生存率及影响患者预后恢复的因素。结果术后20、30、60个月,生存率为77.14%、15.71%、7.14%;患者术前KPS评分、肿瘤部位、年龄、手术切除程度、放化疗及二次手术均影响患者预后的恢复。结论影响胶质母细胞瘤患者预后因素与KPS评分、肿瘤部位、年龄、手术切除程度、二次手术等因素相关,采用放化治疗可有效的延长患者的生命,提高生存率。 Objective To analyze impact glioblastoma cut all the related factors of postoperative outcome of patients. Methods Convenient select our hospital during March 2010-February 2011 treated 70 cases of patients with glioblastoma full cut, all patients after surgical removal of more than 90% of the tumor, consciousness and spirit in good condition. 34 cases were male, 36 cases of female,age 〈55 47 Cases, ≥55 years old,23 cases, analysis of the patient's survival rate and the factors influencing prognosis of patients with recovery. Results 20, 30, 60 months after operation and survival rate was77.14%, 15.71%, 7.14%; Patients with preoperative KPS score, tumor location, age, the degree of surgical removal, radiation and chemotherapy, and influence the prognosis of patients with secondary surgery recovery. Conclusion The factors affecting the prognosis of patients with glioblastoma and KPS score, tumor location, age, degree of resection, secondary surgery and other related factors, using put treatment can effectively extend the life of the patients, improve the survival rate.
作者 卫昕伟
出处 《中外医疗》 2016年第21期108-110,共3页 China & Foreign Medical Treatment
关键词 胶质母细胞瘤 全切术 预后恢复 相关因素 Glioblastoma All the cut method Prognosis of recovery Related factors
  • 相关文献

参考文献5

二级参考文献58

  • 1陈忠平.脑胶质瘤的临床治疗方向[J].中华神经外科杂志,2007,23(2):81-82. 被引量:36
  • 2Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human gliob|astoma genes and core pathways [ J ]. Nature,2008, 455 ( 7216 ) : 1061-1068.
  • 3Abida WM, Gu W. p53-dependent and p53-independent activation of autophagy by ARF [ J ]. Cancer Res, 2008, 68 ( 2 ): 352-357.
  • 4Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D / CDK4 [ J ]. Nature, 1993, 366( 6456): 704-707.
  • 5Gravendeel LA, Kouwenhoven MC, Gevaert O, et al. lntrinsie gene expression profiles of gliomas are a better predictor of survival than histology [ J ]. Cancer Res, 2009, 69 ( 23 ) : 9065-9072.
  • 6Zhang XQ, Sun S, Lain KF, et al. A long non-coding RNA signature in glioblastoma muhiforme predicts survival [J].Neurobiol Dis, 2013, 58: 123-131.
  • 7Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomie analysis identifies elinieally relevant subtypes of glioblastoma ~haraeterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 [ J ]. Cancer Cell, 2010, 17 ( 1 ) : 98-110.
  • 8Belanich M, Pastor M, Randali T, et al. Retrospective study of the cor-relation between the DNA repair protein alkytransferase and survival of brain tumor patients treaded with carmustine [ J ]. Cancer Res, 1996,56(4) :783-788.
  • 9Abe T, Hasegawa S, Taniguchi K, et al. Possible involvement of multi- drug resistance-associated protein (MRP) gene expression in sponta- neous drug resistance to vineristine, etoposide and adriamyein in hu- man glioma cells [ J ]. Int J Cancer, 1994,58 ( 6 ) : 860-864.
  • 10Gosttesman MM. Mechanisms of cancer drug resistance [J]. Annu Rev Med ,2002,53 (4) :615-627.

共引文献6

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部